GPT and metabolic dysfunction-associated steatotic liver disease: Five weeks after viral transduction, signs of MASLD improved dramatically as the liver weight, ALT and AST levels, and hepatic lipid contents decreased in the HFD-treated mice, whereas the body weight remained unchanged (Fig. 2a, b; Supplementary Fig. 3a, b).